Identification of this protein as a putative therapeutic target for sepsis led to the controversial Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study (Bernard et al., 2001). This evidence concerns the gene PROC and Sepsis.